The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, J. Matz, R. Townley, R. Buhl, J. O'Brien, H. Fox, J. Thirlwell, N. Gupta, G. Della Cioppa

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics'. Together they form a unique fingerprint.

Medicine & Life Sciences